Search research articles
Contact Us
Filters
Showing results (221-230 of 280) with videos related to
Page
of 28
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2009
Phase II-I-II study of two different doses and schedules of pralatrexate, a high-affinity substrate for the reduced folate carrier, in patients with relapsed or refractory lymphoma reveals marked activity in T-cell malignancies
Owen A O'Connor, Steven Horwitz, Paul Hamlin, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 4, 2018
The Role of Radiation Therapy in Patients With Relapsed or Refractory Hodgkin Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group
Louis S Constine, Joachim Yahalom, Andrea K Ng, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 10, 2013
A phase II study of a nonmyeloablative allogeneic stem cell transplant with peritransplant rituximab in patients with B cell lymphoid malignancies: favorably durable event-free survival in chemosensitive patients
Craig S Sauter, Juliet N Barker, Lauren Lechner, et al.
Blood
|
January 9, 2015
R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma
Antonio Omuro, Denise D Correa, Lisa M DeAngelis, et al.
Blood
|
May 1, 1997
Recombinant methionyl human stem cell factor and filgrastim for peripheral blood progenitor cell mobilization and transplantation in non-Hodgkin's lymphoma patients--results of a phase I/II trial
C H Moskowitz, P Stiff, M S Gordon, et al.
Blood
|
August 15, 2019
Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087
Robert Chen, Pier Luigi Zinzani, Hun Ju Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 26, 2017
Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma
Robert Chen, Pier Luigi Zinzani, Michelle A Fanale, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 17, 2015
Role of cytotoxic therapy with hematopoietic cell transplantation in the treatment of Hodgkin lymphoma: guidelines from the American Society for Blood and Marrow Transplantation
Miguel-Angel Perales, Izaskun Ceberio, Philippe Armand, et al.
Leukemia & Lymphoma
|
September 10, 2023
Utility of routine pulmonary function test after autologous hematopoietic cell transplantation in lymphoma
Parastoo B Dahi, Sheila Kenny, Jessica Flynn, et al.
Blood
|
December 13, 2017
Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma
Alex F Herrera, Alison J Moskowitz, Nancy L Bartlett, et al.
Page
of 28
Search research articles
Search
Showing results (221-230 of 280) with videos related to
Sort By:
Page
of 28
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2009
Phase II-I-II study of two different doses and schedules of pralatrexate, a high-affinity substrate for the reduced folate carrier, in patients with relapsed or refractory lymphoma reveals marked activity in T-cell malignancies
Owen A O'Connor, Steven Horwitz, Paul Hamlin, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 4, 2018
The Role of Radiation Therapy in Patients With Relapsed or Refractory Hodgkin Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group
Louis S Constine, Joachim Yahalom, Andrea K Ng, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 10, 2013
A phase II study of a nonmyeloablative allogeneic stem cell transplant with peritransplant rituximab in patients with B cell lymphoid malignancies: favorably durable event-free survival in chemosensitive patients
Craig S Sauter, Juliet N Barker, Lauren Lechner, et al.
Blood
|
January 9, 2015
R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma
Antonio Omuro, Denise D Correa, Lisa M DeAngelis, et al.
Blood
|
May 1, 1997
Recombinant methionyl human stem cell factor and filgrastim for peripheral blood progenitor cell mobilization and transplantation in non-Hodgkin's lymphoma patients--results of a phase I/II trial
C H Moskowitz, P Stiff, M S Gordon, et al.
Blood
|
August 15, 2019
Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087
Robert Chen, Pier Luigi Zinzani, Hun Ju Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 26, 2017
Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma
Robert Chen, Pier Luigi Zinzani, Michelle A Fanale, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 17, 2015
Role of cytotoxic therapy with hematopoietic cell transplantation in the treatment of Hodgkin lymphoma: guidelines from the American Society for Blood and Marrow Transplantation
Miguel-Angel Perales, Izaskun Ceberio, Philippe Armand, et al.
Leukemia & Lymphoma
|
September 10, 2023
Utility of routine pulmonary function test after autologous hematopoietic cell transplantation in lymphoma
Parastoo B Dahi, Sheila Kenny, Jessica Flynn, et al.
Blood
|
December 13, 2017
Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma
Alex F Herrera, Alison J Moskowitz, Nancy L Bartlett, et al.
Page
of 28